|
Market Closed -
Japan Exchange
02:30:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 2,424.50 JPY | +0.25% |
|
-2.45% | +11.60% |
| 09-01 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,136B 7.37B 6.34B 5.96B 5.44B 10.17B 697B 10.21B 70.65B 27.31B 357B 27.67B 27.06B | P/E 2027 * |
15.6x | P/E 2028 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 935B 6.06B 5.21B 4.9B 4.48B 8.37B 573B 8.4B 58.15B 22.48B 294B 22.77B 22.27B | EV / Sales 2027 * |
2.04x | EV / Sales 2028 * | 1.98x |
| Free-Float |
81.92% | Yield 2027 * |
3.23% | Yield 2028 * | 3.2% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
OTC Markets
| OPHLF | Delayed | |
|
Börse Stuttgart
| ON4 | Delayed | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Deutsche Boerse AG
| ON4 | Delayed | |
|
Tradegate
| ON4 | Real-time |
Last Transcript : Ono Pharmaceutical Co., Ltd.
| 1 day | +0.25% | ||
| 1 week | -2.45% | ||
| Current month | -1.06% | ||
| 1 month | +0.23% | ||
| 3 months | +7.85% | ||
| 6 months | -2.14% | ||
| Current year | +11.60% |
| 1 week | 2,393 |  | 2,511 |
| 1 month | 2,359 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,674 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.25% | -2.45% | +36.48% | -13.41% | 7.37B | |
| -0.48% | -2.23% | +19.29% | +66.83% | 48.08B | |
| +0.60% | -4.76% | +39.20% | +117.99% | 39.95B | |
| -0.79% | -2.74% | -10.20% | +11.20% | 11.92B | |
| -0.99% | -1.91% | +13.46% | +82.36% | 12.2B | |
| -1.50% | -0.38% | +24.76% | +138.18% | 9.22B | |
| -0.47% | -3.51% | +21.87% | +34.65% | 7.41B | |
| +0.92% | +0.17% | +20.60% | +218.53% | 7.32B | |
| -0.32% | -1.85% | -46.31% | +22.01% | 5.17B | |
| +1.87% | +2.13% | +38.16% | +106.70% | 4.64B | |
| Average | -0.09% | -2.09% | +15.73% | +78.50% | 15.33B | |
| Weighted average by Cap. | -0.15% | -3.09% | +21.42% | +82.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 458B 2.97B 2.56B 2.4B 2.19B 4.1B 281B 4.12B 28.5B 11.02B 144B 11.16B 10.92B | 448B 2.91B 2.5B 2.35B 2.15B 4.01B 275B 4.03B 27.88B 10.78B 141B 10.92B 10.68B |
| Net income | 72.89B 472M 406M 382M 349M 652M 44.68B 655M 4.53B 1.75B 22.88B 1.77B 1.74B | 63.15B 409M 352M 331M 302M 565M 38.71B 567M 3.93B 1.52B 19.83B 1.54B 1.5B |
| Net Debt | -201B -1.3B -1.12B -1.05B -962M -1.8B -123B -1.81B -12.5B -4.83B -63.13B -4.9B -4.79B | -250B -1.62B -1.39B -1.31B -1.2B -2.24B -153B -2.24B -15.52B -6B -78.39B -6.08B -5.95B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | JP¥2,424.50 | +0.25% | 1,218,900 |
| 26-09-07 | JP¥2,418.50 | -1.23% | 1,201,300 |
| 26-09-04 | JP¥2,448.50 | -1.67% | 1,559,800 |
| 26-09-03 | JP¥2,490.00 | +0.81% | 1,481,700 |
| 26-09-02 | JP¥2,470.00 | -0.62% | 1,460,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
